Agios Pharmaceuticals Inc (NASDAQ:AGIO)

90.01
Delayed Data
As of Jul 16
 -0.39 / -0.43%
Today’s Change
51.62
Today|||52-Week Range
99.82
+57.44%
Year-to-Date
Financial & Investment Management Group Ltd Buys Omnicom Group Inc, Blackrock Credit ...
Jul 13 / GuruFocus News - Paid Partner Content
5 Gurus' Stocks in the Health Care Industry
Jul 12 / GuruFocus News - Paid Partner Content
5 Gurus' Stocks in the Health Care Industry
Jul 12 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close90.40
Today’s open89.82
Day’s range88.12 - 91.30
Volume235,745
Average volume (3 months)364,932
Market cap$5.0B
Data as of 4:00pm ET, 07/16/2018

Growth & Valuation

Earnings growth (last year)-33.14%
Earnings growth (this year)+3.72%
Earnings growth (next 5 years)--
Revenue growth (last year)-38.46%
P/E ratioNM
Price/Sales61.92
Price/Book11.31

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+0.32+0.19%
ICPTIntercept Pharmaceut...-3.73-3.84%
HCMHutchison China Medi...+0.01+0.03%
MDCOMedicines Co+0.27+0.67%
Data as of 4:00pm ET, 07/16/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$1.57
Annual revenue (last year)$43.0M
Annual profit (last year)-$314.7M
Net profit margin-731.60%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
CFO &
Head-Corporate Development
Andrew J. Hirsch
Corporate headquarters
Cambridge, Massachusetts

Forecasts